TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real-life. Insights from a national Italian survey

The continuous evolution of renal cell carcinoma classification significantly impacts the pathologists' routine approach. Our survey underscores the importance of ongoing knowledge sharing and heightened awareness for accurately identifying TFE3-rearranged and TFEB-altered renal cell carcinoma and providing further insights on still unsolved issues.

Authors

Institutions

Publication Details

Journal
Pathologica
Published
2025-10-01
DOI
https://doi.org/10.32074/1591-951x-n1518
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real-life. Insights from a national Italian survey

Daniele Liscia, Claudia Covelli, Maria Rosaria Raspollini, Giuseppe Nicolò Fanelli et al.
1 citations
Pathologica
Renal cell carcinoma treatment
1.52
article

TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real-life. Insights from a national Italian survey

Daniele Liscia, Claudia Covelli, Maria Rosaria Raspollini, Giuseppe Nicolò Fanelli, Daniela Onnis, Costantino Ricci, Angelo Giovanni Bonadio, Alessia Moro, Mariia Ivanova, Guido Martignoni, Stefano Marletta, Steno Sentinelli, Paola Del Bianco, Simona Francesconi, Marina Valeri, Anna Caliò
article en
1 citations

Abstract

The continuous evolution of renal cell carcinoma classification significantly impacts the pathologists' routine approach. Our survey underscores the importance of ongoing knowledge sharing and heightened awareness for accurately identifying TFE3-rearranged and TFEB-altered renal cell carcinoma and providing further insights on still unsolved issues.

PathologicaVol. 117(4)
University of Pisa (IT), University of Verona (IT), Humanitas University (IT), University of Cagliari (IT), Azienda Ospedaliera Bolognini Seriate (IT), Casa di Cura Villa Garda (IT), Ospedale San Giacomo Apostolo (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Azienda USL di Bologna (IT), Azienda Ospedaliera S.Maria (IT), Azienda Sanitaria Locale Alessandria (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Ospedaliera G. Brotzu (IT), Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, European Institute of Oncology (IT)
Openalex Percentile: Top 13%
Renal cell carcinoma treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.